Generate QR code
Open Access
Subscription Access
Clinical and microbiological features of pneumonia caused by klebsiella pneumoniae in patients with pulmonary tuberculosis
https://doi.org/10.51922/1818-426X.2025.3.63
Abstract
A retrospective observational “case-control” study was conducted on 80 cases of pneumonia associated with K. pneumoniae, including 40 cases (main group) in patients with tuberculosis (TB) of the respiratory organs and 40 cases in those without TB (comparison group). Each patient of the main group was matched with a patient of the comparison group of the same gender and age group. The article presents the results of the study of clinical and laboratory data of patients, sensitivity of isolated K. pneumoniae strains to antibiotics (AB). Among comorbidities, TB patients with Klebsiella pneumoniae co-infection more often had a history of HIV infection and chronic alcoholism, 27.5 % of patients had no complaints. 72.5 % of patients of the main group and all patients (100 %) of the comparison group noted deterioration of health associated with pneumonia onset (χ2 = 12.75, p < 0.001). Most patients in the comparison group noted cough (χ2 = 12.58, p < 0.001) and fever (χ2= 4.94, p = 0.026). Other complaints found in patients of both study groups had no statistically significant differences. The isolated strains of K. pneumoniae are characterized by a high level of resistance to aminopenicillins, respiratory fluoroquinolones, carbapenems; meanwhile have 100 % sensitivity to colistin and fosfomycin, tigecycline, amikacin was noted.
About the Authors
L. V. Levchenko
УО «Гомельский государственный медицинский университет»;
Belarus
Belarus
V. M. Mitsura
УО «Гомельский государственный медицинский университет»;
ГУ «Республиканский научно-практический центр радиационной медицины и экологии человека»
Belarus
Belarus
E. V. Prokopenko
Учреждение «Гомельская областная туберкулезная клиническая больница»
Belarus
Belarus
References
1. Chen, Z. Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data / Z. Chen, T. Wang and J. Du [et al.] // Zoonoses. – 2025. – Т. 5, № 1. – doi: 10.15212/zoonoses-2024-0061.
2. Zaidi, I. Tuberculosis and Pulmonary Co-Infections: Clinical Profiles and Management Strategies / I. Zaidi, J. Vardha [et al.] // Medical Research Archives. – 2023. – Vol. 11. – iss. 12. – doi: 10.18103/mra.v11i12.4897.
3. Abdulkadir, B. A survey of co-infection of some pathogenic bacteria with TB in patients attending Federal Medical Center Katsina, Nigeria / B. Abdulkadir, U. Abubakar, B. Abdullahi [et al.] // Bayero Journal of Pure and Applied Sciences. – 2020. – Vol. 12, iss. 1. – P. 209–214. – doi: 10.4314/bajopas.v12i1.33s.
4. Pujiaty, S. C. Bacterial and fungal infections in pulmonary tuberculosis patients and the drug sensitivity test patterns / S. C. Pujiaty, S. By. Magdalena, S. Parluhutan [et al.] // Afr J Infect Dis. – 2024. – Vol. 19, iss. 1. – P. 21–28. – doi: 10.21010/Ajidv19i1.3.
5. Shimazaki, T. Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines / T. Shimazaki, T. Taniguchi, N. R. D. Saludar [et al.] // Int J Tuberc Lung Dis. – 2018. – Vol. 22, № 1. – P. 65–72. – doi: 10.5588/ijtld.17.0389.
6. Chebotar', I. V. Pochemu Klebsiella pneumoniae stanovitsya lidiruyushchim opportunisticheskim patogenom [Why Klebsiella pneumoniae is becoming a leading opportunistic pathogen] / I. V. Chebotar', Yu. A. Bocharova, I. V. Podoprigora [et al.] // Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. – 2020. – T. 22, № 1. – S. 4–19. – doi: 10.36488/cmac.2020.1.4-19 [in Russian].
7. Liu, J. Clinical and Microbiological Characteristics of Klebsiella pneumoniae Co-Infections in Pulmonary Tuberculosis: A Retrospective Study / J. Liu Y. Zhang, J. Cai [et al.] // Infect Drug Resist. – 2023. – Vol. 16. – P. 7175–7185. – doi: 10.2147/IDR.S421587.
8. Ishikawa, S. Microorganisms isolated at admission and treatment outcome in sputum smear-positive pulmonary tuberculosis / S. Ishikawa, H. Igari, K. Yamagishi [et al.] // J Infect Chemother. – 2019. – Vol. 25, iss. 1. – P. 45–49. – doi: 10.1016/j.jiac.2018.10.005.
9. Breakpoint tables for interpretation of MICs and zone diameters. Ver. 13.0. 2023. – European Committee on Antimicrobial Susceptibility testing (EUCAST) [Electronic resource]. – Mode of access: https://www.eucast.org/clinical_breakpoints. – Date of access: 08.04.2025.
10. Kim, S. B. A variety of bacterial aetiologies in the lower respiratory tract at patients with endobronchial tuberculosis / S. B. Kim, W. Y. Lee, J. H. Lee [et al.] // PLoS One. – 2020. – Vol. 15, iss. 6. – P. e0234558. – doi: 10.1371/journal.pone.0234558.
11. Ivushkina, L. V. Mikrobiologicheskiy monitoring Klebsiella pneumoniae i mekhanizmy ikh rezistentnosti k antimikrobnym preparatam u bol'nykh tuberkulezom Moskvy [Microbiological monitoring of Klebsiella pneumoniae and mechanisms of their resistance to antimicrobial drugs in patients with tuberculosis in Moscow] / L. V. Ivushkina, A. Yu. Mironov // Klinicheskaya laboratornaya diagnostika. – 2024. – № 69(40). – S. 131–141. – doi: 10.51620/0869-2084-2024-69-4-131-141 [in Russian].
12. Bir, R. Prevalence of Co-infection of Culture-Proven Bacterial Pathogens in Microbiologically Confirmed Pulmonary Tuberculosis Patients From a Tertiary Care Center / R. Bir, R. Ranjan, J. Gunasekaran [et al.] // Cureus. – 2024. – № 16(8). – P. e66482. – doi: 10.7759/cureus.66482.
Review
For citations:
Levchenko L.V., Mitsura V.M., Prokopenko E.V. Clinical and microbiological features of pneumonia caused by klebsiella pneumoniae in patients with pulmonary tuberculosis. Medical Journal. 2025;(3):63-69. (In Russ.) https://doi.org/10.51922/1818-426X.2025.3.63
Views:
56
Email this article 